India's largest drug maker Sun Pharma began the rollout of its anti-cancer product ‘Gemcitabine InfuSMART’, a ready-to-administer bag for oncology treatment in six European countries. Talking about the above development and market share for the product Hellen De Kloet, Biz Head-Western Europe & ANZ, Sun Pharma said the launch will start in the UK and the Netherlands because these are the first two countries in Europe where we have final approval. She said it would be difficult to estimate the revenue potential as of now but expects the market to switch to the ready-to-administer bag in two-three years.
0 comments:
Post a Comment